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ABSTRACT
Polypyrimidine tract-binding protein (PTB) is a
splicing regulator that also plays a positive role in
pre-mRNA 3’ end processing when bound upstream
of the polyadenylation signal (pA signal). Here, we
address the mechanism of PTB stimulatory function
in mRNA 3’ end formation. We identify PTB as the
protein factor whose binding to the human b-globin
(HBB) 3’ UTR is abrogated by a 3’ end processing-
inactivating mutation. We show that PTB promotes
both in vitro 3’ end cleavage and polyadenylation
and recruits directly the splicing factor hnRNP H
to G-rich sequences associated with several pA
signals. Increased binding of hnRNP H results in
stimulation of polyadenylation through a direct
interaction with poly(A) polymerase. Therefore, our
results provide evidence of a concerted regulation
of pA signal recognition by splicing factors bound
to auxiliary polyadenylation sequence elements.
INTRODUCTION
The 30 ends of most RNA polymerase II transcripts are
generated by a nuclear co-transcriptional process that
involves a site-speciﬁc endonucleolytic cleavage event fol-
lowed by the addition of 15–200 adenylate residues (1–4).
In mammals, cleavage and polyadenylation requires the
co-transcriptional assembly of a large complex consisting
of at least six multimeric factors onto a bipartite core
signal (pA signal), composed of the highly conserved A
AUAAA hexamer situated 10–30 nucleotides upstream of
the cleavage site and a more degenerate U- or GU-rich
downstream sequence element (DSE). The pre-mRNA
forms a stable complex through a cooperative interaction
between AAUAAA hexamer-bound cleavage and polya-
denylation speciﬁcity factor (CPSF) and DSE-bound
cleavage stimulatory factor (CstF). Additional factors
are also required such as cleavage factor I (CF I), cleavage
factor II (CF II), poly(A) polymerase (PAP) and nuclear
poly(A)-binding protein (PABPN1). These factors are
both necessary and suﬃcient to reconstitute the 30 end
processing reaction in vitro (5,6). However, optimal
in vivo processing not only depends upon the concerted
recognition of the hexamer and DSE by the core 30 end
machinery but also utilizes additional auxiliary cis-acting
sequence elements and trans-acting factors that have been
reported to modulate processing eﬃciency.
Upstream sequence elements (USE) are U-rich regions
identiﬁed in association with several cellular pA sites
(7–10). A number of factors have been identiﬁed as
USE-binding proteins, including splicing factors of
the hnRNP and SR protein families and polyadenylation
factors. Among the splicing factors, polypyrimidine tract-
binding protein (PTB), a major hnRNP protein that plays
multiple roles in mRNA metabolism, has been frequently
found to associate with USEs. In particular, PTB has
been shown to interact with the USE of complement C2
(C2), prothrombin (F2) and cyclooxigenase-2 (COX-2)
pre-mRNAs where it enhances 30 end processing eﬃciency
(7,10,11). Contrastingly, PTB binding to the DSEs of the
human a-globin and b-globin (HBB) pre-mRNA pA sig-
nals decreases the eﬃciency of 30 end cleavage (12). A
similar inhibitory function of DSE-bound PTB has been
observed for the C2 pA signal, thus revealing that PTB
may play a role in both activation and repression of poly-
adenylation (12). While the competition between PTB and
CstF 64 for binding to the DSE can account for the gen-
eral inhibitory function of PTB (12), the molecular
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bound to upstream enhancer elements remains unclear.
In contrast to USEs, auxiliary sequence elements
located downstream of the pA site (AUX-DSEs) are less
frequently characterized. The best described AUX-DSE is
the G-rich sequence element (GRS) found downstream of
the SV40 late (SVL) pA signal (13–16). The SVL GRS
which serves as a binding site for the splicing and poly-
adenylation factor hnRNP H (13, 15), has been proposed
to stimulate 30 end processing by stabilizing the binding
of CstF to the DSE (15,17–19). Similarly, GRSs which
exhibit a stimulatory function on 30 end cleavage through
the binding of hnRNP H have been found associated with
other pA signals (13,15,20,21).
The importance of auxiliary regulatory sequence ele-
ments for 30 end processing is highlighted by the increasing
number of human diseases in which this process is deregu-
lated by mutations in cis-regulatory sequences (4).
The HBB 30 end processing reaction is highly susceptible
to b-thalassemia causing mutations within both the core
polyadenylation elements and the ﬂanking regulatory
sequences (4). We previously reported that b-thalassemia
mutations within the last splice acceptor site of HBB pre-
mRNA reduce the binding of the splicing factor U2AF65
and interfere with the eﬃciency of 30 end cleavage (22).
In this report, we have investigated the mechanism by
which the naturally occurring b-thalassemia term+6 (C to
G) mutation, located 6 bases after the stop codon of the
HBB 30 UTR, reduces 30 end cleavage eﬃciency (23). We
show that the mutation resides in an evolutionary con-
served pyrimidine tract and that it impairs the binding
of PTB to this element. In agreement with the enhancing
function of PTB in 30 end processing, PTB tethered
upstream of the HBB pA signal stimulates in vitro clea-
vage/polyadenylation reactions and enhances the RNA
binding activity of hnRNP H. Increased binding of
hnRNP H results in stimulation of polyadenylation
through a direct interaction with PAP. Importantly,
PTB enhances hnRNP H recruitment to other PTB-regu-
lated pA signals, suggesting that the interaction between
the two splicing factors plays a general role in pA signal
recognition.
MATERIALS AND METHODS
RNA substrates
DNA templates for in vitro transcription were obtained by
two rounds of PCR. The forward primers containing the
r17 sequence upstream of the indicated gene-speciﬁc
sequence and reverse primers used in the ﬁrst PCR were
the following: HBB pA signal, forward: 50-AATTTCTAT
TAAAGGTTCCTT-30 and reverse: 50-GTTTGAACTAG
CTCTTCATTTCTTTATG-30; C2 pA signal, forward:
50-ATGGAATTTCCCAGTTAT-30 and reverse: 50-GCT
CTTGGAGTCATTCTGGC-30; F2 pA signal, forward:
50-CTAAAACTATGGTTCCCAAT-30 and reverse: 50-T
CCCACCTCAGCCTCCCGAG-30.
In the second round of PCR, the three PCR products
were ampliﬁed using a forward primer containing the
T7 promoter sequence upstream of the r17 sequence and
reverse primers as in the ﬁrst round of PCR. Capped,
uniformly
32P-labeled RNAs used for cleavage, polyade-
nylation and UV cross-linking assays were obtained by
in vitro transcription of these PCR products. The L3 pA
signal was obtained by in vitro transcription of the R17-L3
linearized plasmid as previously described (22).
Cleavage and polyadenylation reactions
In vitro cleavage reactions were performed by incubating
32P-labeled RNA substrates with nuclear extracts (NE) for
90min at 308C in the presence of puriﬁed recombinant
GST–R17 or GST–R17–PTB fusion proteins as pre-
viously described (24). The in vitro polyadenylation
assays using NE were performed for 15min at 308Ca s
for the cleavage reaction except that it was done without
cordycepin and in the presence of 0.7mM ATP and
Mn
2+. hnRNP H/F depleted NE were performed by
three consecutive rounds of incubation of NE with 1mg
of streptavidine/agarose-bound SVL GRS for 1h at 48C.
Alternatively, sequestration of hnRNP H/F was per-
formed by addition of 1mg of SVL GRS (or a control
RNA) in the cleavage assay. Reconstituted polyadenyla-
tion reactions were performed for 15min at 378Ca s
described in ref. (24). Analysis and quantiﬁcation of clea-
vage/polyadenylation reactions after RNA extraction and
resolution on a denaturing 6% polyacrylamide gel was
done by PhosphorImager (Molecular Dynamics) analysis.
Cleavage activity was calculated by dividing the amount
of upstream cleavage product by the sum of cleavage
plus precursor products. Polyadenylation eﬃciency was
calculated by dividing the pre-cleaved product by the poly-
adenylated product.
UV crosslinking/IP
Puriﬁed GST-tagged R17, R17–PTB or PTB proteins
were incubated with
32P-labeled transcripts corresponding
to the HBB, C2, F2 or L3 pA signals under cleavage con-
ditions for 30min at room temperature. The reaction mix-
tures were then irradiated on ice with UV light (254nm) in
a Stratalinker (Stratagene) at 0.4J/cm
2 at 10cm distance.
Then, 50 units of RNAse ONE (Promega) was added and
the reaction mixtures were incubated for 30min at 378C.
SDS gel loading buﬀer was added and the samples were
boiled for 2min before fractionation on a 10% SDS–
PAGE. For IP analysis, protein G sepharose was incu-
bated with antibodies prior to addition of UV-crosslinked
complexes in NETN buﬀer (20mM Tris at pH 8.0,
100mM NaCl, 0.5% NP-40, 0.5mM EDTA). After 1h
at 48C, bound proteins were washed six times with
NETN buﬀer and eluted by adding SDS loading buﬀer
to the beads. Antibodies used were hnRNP H/F (mAb
1G11, Abcam), PTB (mAb Bb7, Abcam), U2AF65
(mAb MC3;a gift of M. Carmo-Fonseca), CFIm (poly-
clonal; a gift of W. Keller), CstF 64 (mAb 3A1; a gift of
C. McDonald).
Bioinformatical sequence motif search
In order to select genes with the PYR2 consensus motif
[C/T]TTTC[C/T]TGCT in their 30 ends, we developed
three custom bioinformatics programs that extract
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expressions and then partition the sequences based on
their motif content/topology. The extraction used the
UCSC human genome sequence (hg18) in conjunction
with the transcript coordinates provided by the
refFlat.txt SQL dump and the polyA prediction track
ﬁle polyApredict.txt. Coordinates of transcripts and
polyA sites were used to extract genomic sequences
encompassing all 30 UTR exons and downstream genomic
sequences. A set of regular expressions were generated
to match the sequence motifs of interest and to search
the above-mentioned 30 end sequence database. Finally,
a program was developed to partition all sequences with
matching motifs based on the order and proximity of the
motifs in order to select the ﬁnal set of genes that con-
tained the desired motif topology.
Recombinant proteins
GST fusion proteins were cloned in the pGEX-2T E. coli
expression vector. His-tagged hnRNP H and hnRNP F
encoding plasmids were kindly provided by Douglas
Black. All fusion proteins were expressed in E. coli at
208C overnight and puriﬁed to homogeneity by glu-
tathione agarose chromatography. The His-tagged
bovine PAP (residues 1–694), hnRNP H and hnRNP F
were puriﬁed to homogeneity by Ni
2+–NTA chroma-
tography as described in ref. (25). Recombinant
puriﬁed PABP was kindly provided by Maria Carmo-
Fonseca.
GST pull-down assays
GST pull-down assays were performed by incubating 1mg
of puriﬁed GST–R17 or GST–R17–PTB bound to 20ml
of glutathione agarose beads with 200mg of HeLa NEs
(Figure 3a) in NETN buﬀer (20mM Tris at pH 8.0,
100mM NaCl, 0.5% NP-40, 0.5mM EDTA) for 60min
at 48C. Beads were then washed ﬁve times, treated with
10mg/ml RNAse A at room temperature for 30min and
washed again. Protein elution was performed by adding
SDS loading buﬀer to the beads. Eluted proteins were
resolved by 10% SDS–polyacrylamide gel electrophoresis
(PAGE) and analyzed by western blot. GST pull-
down assays shown in Figures 3b and 6g and h were per-
formed as described above except that it was done with
1mg of His-tagged hnRNP H, hnRNP F or PAP, and
bound proteins were visualized by Coomassie blue
staining.
RESULTS
PTB binds to a pyrimidine tract upstream of the HBB
pA signal
Previous data have shown that the term+6 mutation in
the HBB 30 UTR causes b-thalassemia by interfering with
correct 30 end formation (23). Analysis of the sequence
surrounding the mutation revealed that it resides within
a region containing a long series of pyrimidine residues,
which represents a potential PYR tract (named PYR2,
Figure 1a). This pyrimidine-rich sequence closely
resembles the HBB IVSII PYR tract (named PYR1;
Figure 1a) at the IVSII 30 splicing site that binds
U2AF65 and is involved in 30 end processing (22,24).
In order to determine the protein factor(s) that bind to
PYR2 and that may be involved in the mechanism by
which the term+6 mutation aﬀects 30 end processing, we
performed UV crosslinking and immunoprecipitation (IP)
experiments. UV crosslinking using a
32P-end labeled
RNA oligonucleotide corresponding to PYR2 (PYR2
RNA) in the presence of HeLa cell NEs produced three
major bands (Figure 1b). The term+6 mutation within
PYR2 (term+6 RNA) abolished the binding of a protein
of 55kDa. This band was identiﬁed as PTB by IP of the
UV-crosslinked complexes with the PTB antibody
(Figure 1c). No IP bands were detectable using either
the mutated RNA or a mock IP (Figure 1c), indicating
that binding of PTB to PYR2 RNA was eliminated by the
term+6 mutation.
Next, we performed UV crosslinking experiments
using recombinant, puriﬁed PTB. Even the highest con-
centrations of PTB were only able to bind to the wild-type
PYR2 RNA (Figure 1d). As U2AF65 has been found by
us (22) and others (11) to regulate 30 end processing by
binding to upstream pyrimidine-rich regulatory elements,
we next determined whether this splicing factor was able
to bind to PYR2 RNA. UV crosslinking/IP experiments
with the U2AF65 antibody gave a strong immunoprecipi-
tated complex with PYR1 RNA, while only a faint
band was detectable with PYR2 RNA (Figure 1e). This
suggests that U2AF65 more closely associates with the
PYR1 compared to the PYR2 RNA.
Taken together, these results demonstrate that the HBB
term+6 mutation impairs the binding of PTB to the
PYR2 element and that PTB, but not U2AF65, may be
the factor involved in the mechanism of 30 end processing
deregulation induced by this genetic defect.
PTB bound upstream of the pA signal stimulates 3’-end
cleavage
PTB has been shown to play an inhibitory function in the
HBB 30 end processing by competing with the cleavage
factor CstF 64 for the U-rich DSE (12). We therefore
investigated the function of PTB bound upstream of the
HBB pA signal by tethering a R17/MS2-PTB fusion pro-
tein to a
32P-labeled HBB pre-mRNA containing a high-
aﬃnity R17 binding site (named r17) in place of PYR2
(Figure 2a) and using NEs. No cleavage product was
observed with an RNA substrate containing a AAUAA
A to AAGAAA mutation in the HBB pA signal
(Figure 2b). Addition of R17–PTB, but not R17 alone,
increased cleavage eﬃciency in a dose-dependent manner
up to 2-fold (Figure 2b). Similar results were obtained
using the r17/adenovirus L3 (L3) pA signal substrate
(Figure 2c), suggesting a more general positive function
of PTB in 30 end cleavage when bound upstream of a pA
signal.
PTB interacts directly with hnRNP H
In order to dissect the molecular mechanism whereby PTB
stimulates 30 end processing, we wished to identify
4674 Nucleic Acids Research, 2009, Vol. 37,No. 14proteins with which PTB interacts. As PTB and hnRNP H
form a cooperative assembly on the splicing downstream
control sequence element of the c-src pre-mRNA (26),
we tested the interaction between PTB and hnRNP H
family regulators of 30 end processing, including hnRNP
H/H0 and hnRNP F. To this end, we performed a glu-
tathione S-transferase (GST) pull-down experiment using
GST–R17–PTB and NEs. Western blot analysis with an
hnRNP H/F antibody detected both hnRNP proteins,
suggesting an interaction between PTB and both hnRNP
H and F (Figure 3a). No protein–protein interactions were
found between PTB and two other 30 cleavage/polyadeny-
lation factors, CstF 64 and CFIm, which are often targeted
by 30 end processing regulators (Figure 3a). GST pull-
down assays using only recombinant proteins revealed
that hnRNP H was able to bind to GST–R17–PTB but
not to the control GST–R17 fusion protein; no binding
was observed for hnRNP F (Figure 3b).
We therefore conclude that PTB binds directly
to hnRNP H. The interaction between PTB and hnRNP
F shown in Figure 3a is probably indirect and mediated
by the ability of hnRNP H to heterodimerize with
hnRNP F (27).
HnRNP H regulates 3’ end formation of HBB
pre-mRNA by binding to a G-rich AUX-DSE
The results shown in Figure 3 raise the possibility that the
interaction between PTB and hnRNP H may be involved
in the stimulatory eﬀect of PTB on 30 end processing. If so,
we would expect that hnRNP H is able to modulate HBB
pre-mRNA 30 end processing eﬃciency by binding to a
GRS ﬂanking the core pA signal. Analysis of the HBB
region downstream of the DSE revealed the presence of
a putative GRS located 45 nucleotides downstream of the
cleavage site (named DGRS, Figure 4a). To ascertain
whether hnRNP H binds to this sequence element,
we performed UV crosslinking assays using
32P-labeled
RNA substrates corresponding to the HBB 30 ﬂanking
region containing either wild-type (WT) or mutant
(Mut) DGRS in the presence of NEs. A comparison of
the UV crosslinking patterns of WT and Mut substrate
RNAs revealed a speciﬁc band at 55kDa that disappeared
with the G-to-C/A mutation (Figure 4b). IP of the cross-
linked complexes with the hnRNP H/F antibody showed
that the 55-kDa band corresponds to hnRNP H/F and
that the G-to-C/A mutation mostly abolished hnRNP
H/F binding to the DGRS (Figure 4c).
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30 end cleavage by performing in vitro cleavage assays
using NEs that had been either mock or depleted of endo-
genous hnRNP H/F and add-back experiments using
recombinant hnRNP H or F. The endogenous hnRNP
H/F was eﬃciently depleted by incubation of NEs with
a biotinylated RNA containing the SVL GRS and strep-
tavidin–agarose (Figure 4d). As shown in Figure 4e, deple-
tion of hnRNP H/F reduced 30 end cleavage compared
to mock-depleted extracts. Adding back recombinant
hnRNP H restored 30 end cleavage in depleted extracts
(Figure 4e), while raising the level of hnRNP H in mock
extracts increased the formation of the 30 end cleavage
product (Figure 4e). Unlike hnRNP H, add-back experi-
ments with hnRNP F did not restore 30 end processing in
depleted extracts nor did increasing the amount of hnRNP
F reduce 30 end cleavage in mock NEs (Supplementary
Figure S1). Similar results were obtained by performing
30 end cleavage assays in the presence of SVL GRS RNAs
that sequester hnRNP H/F from the 30 end processing
complex (Supplementary Figure S2).
Collectively, our results show that the 30 end processing
of the HBB pA signal can be modulated by hnRNP
H binding to the GRS downstream of the cleavage site.
PTB bound upstream of the pA signal recruits hnRNP
H to the pre-mRNA
To investigate whether PTB was able to recruit hnRNP H
to HBB transcripts, we analyzed hnRNP H RNA binding
activity upon addition of R17–PTB using UV crosslink-
ing/IP experiments. The
32P-labeled r17/HBB pA signal
RNA was incubated in NEs followed by the addition of
the recombinant R17–PTB. The UV crosslinking pattern
showed an increase in the binding of a 55-kDa species
upon addition of R17–PTB (Figure 5a). This band was
identiﬁed as hnRNP H/F by IP of the crosslinked proteins
with the hnRNP H/F antibody (Figure 5b). Addition of
R17–PTB (Figure 5b), but not of R17 (Figure 5b) or of
PTB alone (Figure 5c), resulted in an enhanced hnRNP
H crosslinking only in the presence of a WT DGRS
(Figure 5d), suggesting that the physical interaction
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across the HBB pA signal.
In order to better characterize the eﬀect of PTB on
the RNA-binding activity of both hnRNP H and F, we
performed UV crosslinking assays using only the r17/HBB
pA signal substrate and recombinant proteins. Addition
of R17–PTB strongly increased the binding of hnRNP H
to the HBB substrate (Figure 5e). The eﬀect of R17–PTB
on hnRNP F binding to the RNA is less pronounced with
hnRNP F alone but stronger in the presence of hnRNP H
(Figure 5e). We therefore conclude that PTB bound
upstream of the HBB pre-mRNA pA signal directly sti-
mulates the binding of hnRNP H and indirectly helps
recruit hnRNP F through heterodimerization with
hnRNP H.
We next asked whether PTB was able to recruit hnRNP
H on other pA signals that are modulated by PTB
and possess a GRS downstream of the cleavage site.
We performed UV crosslinking/IP assays using NEs and
32P-labeled RNA substrates corresponding to the C2 and
F2 pA signals containing the r17 moiety in place of the
natural PTB-binding site (Figure 5f). Since the L3 pA
signal can be regulated by PTB (Figure 2c), we also
tested the r17/L3 pA substrate. As shown in Figure 5f
(left panel), R17–PTB bound to sequences upstream of
several pA signals stimulated hnRNP H binding to the
RNA. This stimulatory eﬀect was stronger when perform-
ing UV crosslinking of the r17/C2 or the r17/F2 substrates
using only recombinant hnRNP H and R17–PTB
(Figure 5f, right panel). Overall, these results suggest a
more general stimulatory eﬀect of PTB on the hnRNP
H-RNA interaction.
PTB simulates polyadenylation by recruiting hnRNP H
on a GRS located upstream of the pA signal
We next analyzed whether PTB was able to inﬂuence
polyA addition through its recruitment of hnRNP H to
GRSs upstream of the pA signal. This hypothesis is based
on previous studies that suggest an implication of PTB or
hnRNP H in polyadenylation (7,10,11). In addition, we
identiﬁed a putative hnRNP H binding site between PYR2
and the pA signal of the HBB pre-mRNA (named UGRS,
Figure 6a).
To verify this hypothesis, we performed in vitro poly-
denylation reactions with NEs using a
32P-labeled r17/
HBB pre-cleaved substrate (Figure 6a). We ﬁrst tested
whether PTB functions as a regulator of the polyadenyla-
tion reaction. Addition of recombinant PTB stimulated
addition of adenosine residues in a dose-dependent fash-
ion (Figure 6b) to an extent similar to that obtained in
the presence of the 30 end processing regulator U2AF65
(Figure 6b) (24).
To investigate the possible involvement of the PTB–
hnRNP H interaction in the stimulatory eﬀect of PTB
on polyadenylation, we checked if PTB stimulated the
interaction between hnRNP H and the pre-cleaved sub-
strate using UV crosslinking/IP experiments with NEs. As
expected, the UV crosslinking pattern of the pre-cleaved
substrate was remarkably distinct in the 50-kDa region
(Figure 6c), from that generated with the substrate includ-
ing the HBB 30 ﬂanking region (Figure 5a). However,
the addition of R17–PTB still resulted in an increased
crosslinked protein at this molecular size (Figure 6c). IP
of the crosslinked complexes with the hnRNP H/F anti-
body conﬁrmed that hnRNP H is the protein factor whose
binding is potentiated by addition of R17 linked to PTB
(Figure 6d).
If the increased binding of hnRNP H to the RNA is
responsible for the stimulation of pA addition by PTB,
then it should be possible to reproduce the stimulatory
eﬀect by increasing the amount of recombinant hnRNP
H in a polyadenylation assay. To test this possibility,
we performed reconstituted polyadenylation assays using
only recombinant PAP, PABPN1, hnRNP H or F and
R17–PTB. As shown in Figure 6e, the polyadenylation
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Figure 3. PTB interacts directly with hnRNP H, but not with hnRNP
F. (a) In vitro GST pull-down assay using GST-tagged R17–PTB or
R17 proteins and NEs, visualized by SDS–PAGE and followed by
western blot analysis using antibodies against hnRNP H/F, CFIm 68
or CstF 64. A 1/20th equivalent of the input NE is shown in lane 1.
The experiments were carried out in the presence of RNase A, suggest-
ing that the interaction was not mediated through RNA binding.
(b) In vitro GST pull-down assay using GST-tagged R17–PTB or
R17 proteins and recombinant His-tagged hnRNP F or hnRNP H,
and this was analyzed by Coomassie staining of SDS–PAGE. The
input lanes account for 10% of hnRNP H and hnRNP F used in the
assay, respectively.
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increased by the addition of hnRNP H. Conversely, when
the polyadenylation reaction occurred in the presence
of hnRNP F, the polyadenylation activity of PAP
was signiﬁcantly reduced (Figure 6e). While additional
experiments are needed to further investigate the inhibi-
tory activity of hnRNP F on polyadenylation, our results
conﬁrm that hnRNP H plays a role in stimulating pA
addition. We next tested whether this stimulatory eﬀect
can be further potentiated in the presence of R17–PTB.
R17–PTB was able to modify PAP activity only slightly
(Figure 6f) suggesting that the stimulation of pA addition
by R17–PTB in NEs does not rely on a direct eﬀect of
PTB on PAP. Interestingly, when both R17–PTB and
hnRNP H were included in the reconstituted polyadenyla-
tion assay, the stimulatory activity of hnRNP H on
poly(A) tail elongation was further increased compared
to hnRNP H alone (Figure 6f). A possible explanation
for these results is that PTB recruits PAP indirectly by
means of its direct interaction with hnRNP H. This
hypothesis implies that hnRNP H and PAP interact
directly. We tested this possibility by performing GST
pull-down assays using recombinant GST–PTB, hnRNP
H and PAP and found that PTB was able to interact with
hnRNP H but not with PAP alone (Figure 6g).
Conversely, when both PAP and hnRNP H were present
in the assay, PAP was pulled down by PTB (Figure 6g),
suggesting that the binding of PTB to PAP is mediated
by hnRNP H. To conﬁrm this possibility using the same
proteins as in the functional and pull-down assays, we
immunoprecipitated hnRNP H and checked whether
PAP was found in the IP fraction. As shown in
Figure 6h, PAP was pulled down only in the presence of
hnRNP H.
Taken together, these results show that PTB bound
upstream of the HBB pA signal facilitates the association
of hnRNP H with a GRS that in turn recruits PAP
thereby stimulating pA addition.
The HBB PYR2 element is conserved and can be found
in other pA signals
Our results highlight the importance of the PYR2 ele-
ment for eﬃcient HBB pre-mRNA 30 end processing.
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4678 Nucleic Acids Research, 2009, Vol. 37,No. 14element reduces both the binding of PTB and 30 end pro-
cessing eﬃciency. A sequence alignment of the 30 ends of
vertebrate HBB genes revealed that the nucleotide aﬀected
by the b-thalassemia mutation and the sequence surround-
ing this base are highly conserved among higher verte-
brates (Figure 7). The sequence surrounding the
mutation is the pyrimidine-rich region (9 pyrimidines out
of 10 nucleotides of the most strongly conserved element)
with only two pyrimidine transitions. The upstream, con-
served element is also positionally preserved. To gain
insight into the possible involvement of this sequence in
the control of 30 end formation of other mRNAs, we ana-
lyzed if other human mRNAs contain the sequence
[C/T]TTTC[C/T]TGCT upstream of the pA signal. We
identiﬁed 60 genes that contain this element in their pA
signal region. Interestingly, 56 out of the 60 identiﬁed
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of the pA signal (Supplementary Table S1).
DISCUSSION
Bioinformatic analyses of the sequence surrounding
the pA signal identiﬁed, in addition to the core elements,
auxiliary over-represented cis-acting sequences, including
U-rich upstream motifs and GRSs positioned both
upstream and downstream of the pA signal (28). Both
cis-elements have an enhancing function in 30 end forma-
tion through the binding of trans-acting proteins, includ-
ing two splicing regulators, PTB and hnRNP H. PTB
interacts with the U-rich USE and stimulates 30-end cleav-
age by an unknown mechanism (7,10,11), whereas hnRNP
H binds to the GRS located at the AUX-DSE and pro-
motes 30 end formation by increasing the binding of
CstF64 to the core pA signal (15,17–19). Our in vitro func-
tional studies show that PTB and hnRNP H positively
regulate both steps of HBB pre-mRNA 30 end processing
by binding to an upstream U-rich element and two GRS
sequences positioned on either side of the pA signal,
respectively. More importantly, we demonstrate that
PTB bound to the upstream element facilitates the inter-
action between hnRNP H and the two GRSs proximal to
the HBB pA signal and that this physical interaction plays
an enhancing function in both steps of 30 end formation.
Thus, we provide evidence of a concerted regulation of pA
signal recognition by splicing factors bound to auxiliary
polyadenylation sequence elements.
On the basis of three main ﬁndings, we propose that this
is a general mechanism of 30 end processing regulation.
First, we have found that the HBB pyrimidine U-rich ele-
ment is associated with 60 pA signals and that 92% of
these pA signals also possess a GRS upstream and/or
downstream of the core element (Supplementary
Table S1). This result suggests that PTB bound to the
pyrimidine U-rich element may function to modulate the
30 end processing eﬃciency of other pA signals and that
hnRNP H may be involved in this stimulatory eﬀect.
Second, the sequence analysis of several PTB-regulated
pA signals (including the C2, F2, proximal COX-2 and
CT/CGRP exon 4 pA signals) has revealed that all of
these pA signals contain a GRS in the proximity of the
core pA element. Moreover, in the case of the C2 and
F2 pA signals, we show that PTB stimulates hnRNP H
binding to RNA (Figure 5f). Finally, we show that the
strong L3 pA signal can also be positively regulated by
PTB bound upstream of the AAUAAA hexamer and that
this stimulatory eﬀect is associated with increased binding
of hnRNP H, presumably to a G-rich motif present in
the functional AUX-DSE (17; our observation).
One clue to the mechanism by which PTB stimulates 30
end processing via recruitment of hnRNP H comes from
the observation that all of the pA signals considered in this
study are associated with weak hnRNP H binding sites.
Indeed, hnRNP H was identiﬁed as the protein factor
that strongly binds to the SVL GRS. This element has
the propensity to form G-quadruplex structures (29),
and RNA secondary structures have been shown to play
a role in polyadenylation (30,31). In addition, mutational
analysis of the SVL GRS revealed that mutations disrupt-
ing the G-quadruplex structure not only aﬀect the func-
tion of the GRS in the 30 end processing of the SVL late
pA signal but also reduce the GRS–hnRNP H interaction
(19). Both GRS elements of the HBB pA signal do not
form G-quadruplex structures according to bioinformatic
prediction (QGRS mapper, (32) and our experimental
observations (A.D., unpublished data), indicating that
they may represent weak binding sites for hnRNP H.
However, previous studies have shown that hnRNP H is
able to stimulate 30 end processing even when bound to
weak binding sites and suggest that an accessory factor is
needed to strengthen hnRNP H association and potentiate
its stimulatory function (13). In agreement with this
hypothesis and with the general view that auxiliary cis-
acting motifs aid in the use of suboptimal polyadenylation
sequence elements, we propose that PTB, bound to
upstream auxiliary elements, exerts its stimulatory func-
tion by associating hnRNP H with suboptimal GRS ele-
ments and facilitating the assembly of the polyadenylation
machinery (Figure 8).
The occurrence of a molecular and functional link
between PTB and hnRNP H bound to their cis-regulatory
elements may be critical for pA signals that ineﬃciently
recruit the polyadenylation machinery due to U/GU-rich
DSEs that are suboptimal for CstF binding, such as the
DSEs from C2 and F2. For both pA signals, PTB bound
to the USE stimulates both 30 end processing eﬃciency
(7,11) and hnRNP H binding (Figure 5). Increased asso-
ciation of hnRNP H stimulates the association of a stable
complex between CstF64 and the DSE (14,15,17–19).
Unlike the F2 and C2 pA signals, the HBB pA signal
consists of a consensus CPSF binding site and a U-rich
DSE and is therefore very eﬃcient in terms of 30 end
processing. For this strong pA signal, the function of
cis-auxiliary sequences is to further improve the clea-
vage/polyadenylation reaction, as shown for the pyrimi-
dine tract near the last intron 30 splice site (24) or for the
heterologous F2 USE inserted upstream of the HBB pA
signal (11). The b-thalassemia term+6 mutation reduces
30 end eﬃciency by 22–30% (23), in agreement with the
moderate ability of cis-regulatory sequences to modulate
the eﬃciency of pA signals. As expected for a pA signal
with a strong DSE, the PTB-induced increase in hnRNP H
binding does not result in an enhanced binding of CstF
64 to the HBB cleavage substrate (data not shown).
TAAGCTCGCTTTCTTGCTGTCCAA Homo sapiens
TAAACCCCCTTTCCTGCTCTTGCC Mus musculus
TAAGCTCACTTTCTTGCTGTCCAA Macaca mulatta
TAAGCTCCCTTTCCTGCTTTCCAG Bos taurus
TAAACCTCTTTTCCTGCTCTTGCT Rattus norvegicus
TGAGCTC-CTTTCCTGCTACTGAG Galago crassicaudatus
Figure 7. Eukaryotic conservation of the PTB-bound pyrimidine-rich
element within the HBB 30 UTR as demonstrated by multiple sequence
alignment.
Nucleic Acids Research, 2009,Vol.37, No. 14 4681Consequently, the stimulatory function of hnRNP H
might involve other components of the polyadenylation
machinery. Our results show that hnRNP H stimulates
pA addition in reconstituted polyadenylation assays
(Figure 6e and f) and that it interacts with PAP
(Figure 6g and h), implying that a PAP–hnRNP H inter-
action plays a role in the stimulatory function of PTB.
Since PAP is often involved in both 30 end cleavage and
polyadenylation processes (33), a possible mechanism is
that PTB stimulates the binding of hnRNP H to GRSs
and that hnRNP H, in turn, enhances PAP activity in both
steps of mRNA 30 end formation (Figure 8). According to
this model and considering that the recruitment of PAP to
pA signals is a late event in the assembly of the pA
machinery, modulation of PAP association through
PTB–hnRNP H concerted regulation can only moderately
modify HBB cleavage eﬃciency. Since CstF can also
enhance polyadenylation when bound to upstream cis-
elements (7), it is possible that hnRNP H stimulates
CstF binding to the upstream region and promotes pA
addition. Although it will be important to study interac-
tions between hnRNP H and other components of the
polyadenylation machinery, we propose that hnRNP H
primarily inﬂuences 30 end processing activity through
PAP and CstF and that these interactions constitute the
main determinant of PTB-mediated 30 end processing
regulation.
We have previously shown that b-thalassemia causing
mutations within the 30 splice site pyrimidine tract inter-
fere with correct HBB pre-mRNA 30 end processing by
reducing the ability of U2AF65 to recruit CF Im to the
pA signal (22, 24). In this study, we demonstrate that the
term+6 mutation in the HBB 3 UTR, which reduces 30
end processing, impairs the binding of PTB to a pyrimi-
dine U-rich element. Our results show that a PTB-induced
increase in binding of hnRNP H to GRS elements
can account for the positive function of PTB in 30 end
processing. Based on our results, we propose that dis-
ease-causing mutations not only disrupt the interactions
between an mRNA and a trans-acting factor, but also
disable the formation of synergistic complexes that regu-
late and perform 30 end processing reactions.
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